At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,712 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Treatment Patterns and 6 and 12-Month Effectiveness of Tofacitinib in the Corrona Rheumatoid Arthritis Registry
In Brief
An observational study for Arthritis, Rheumatoid. Completed, enrolled 1,712 participants across 1 site.
Detailed Summary
This study is to investigate and describe the treatment patterns and effect of tofacitinib indicators for patients with Rheumatoid Arthritis (RA) assessing real world patient data entered in the Corrona RA Registry on or after November 2012
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsArthritis, Rheumatoid
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartJan 2021
First PostedJan 2021
Primary CompletionNov 2021
TodayJul 2026
First PostedJan 25, 2021
Enrollment StartJan 22, 2021
Primary CompletionNov 24, 2021
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 5.4 years ago